Propanedinitrile, 2-​[methoxy(4-​phenoxyphenyl)​methylene]​- | CAS:330792-69-3

We serve Propanedinitrile, 2-​[methoxy(4-​phenoxyphenyl)​methylene]​- CAS:330792-69-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Chemical Name: Propanedinitrile, 2-​[methoxy(4-​phenoxyphenyl)​methylene]​-
CAS.NO:330792-69-3
Synonyms:
2-(methoxy(4-phenoxyphenyl)methylene)malononitrile
Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-
Ibrutinib intermediate

Molecular Formula: C17H12N2O2
Molecular Weight:276.28900

Physical and Chemical Properties:
Density: /
Boiling point: /
Melting point: /
Flash point:/
Refractive index: /

Specification:
Appearance: White  powder
Purity:≥98%
Moisture Content: Not more than 1.0%
Impurity: Not more than 1.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of IdelalisibCAS:870281-82-6

Contact us for information like Propanedinitrile, 2-​[methoxy(4-​phenoxyphenyl)​methylene]​- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ibrutinib intermediate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Propanedinitrile, 2-​[methoxy(4-​phenoxyphenyl)​methylene]​- Use and application,Propanedinitrile, 2-​[methoxy(4-​phenoxyphenyl)​methylene]​- technical grade,usp/ep/jp grade.


Related News: Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.dCMP manufacturer Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.7-Azabenzotriazol-1-Yloxytris(Dimethylamino)Phosphonium Hexafluorophosphate supplier Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.p-Nitrophenyl 2-(Furfurylsulfinyl)acetate vendor But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off.But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off.